Thomas Jefferson Award Recipient
Mark Raper
Chairman & CEO, CRT/tanaka
As chairman and CEO of CRT/tanaka, Mark Raper has led the company to become one of the largest independent public relations firms in the country. Clients from all industries respect his candid, insightful counsel that draws upon his leadership roles within Fortune 500, not-for-profit and consulting organizations.
Raper has worked with major consumer brands, B2B marketers and retailers. In his 20+ years in public relations, he has worked in many aspects of health care marketing, from launching new prescription medications to developing cause-related marketing campaigns and promotions for brands such as Robitussin, Dimetapp and Advil. Prior to his work in the PR agency world, Raper served as director of marketing for Sentara Healthcare, where he was a member of the communications team for the birth of the first in-vitro baby born in the United States. He also previously served as manager of divisional public relations and advertising for Figgie International, a 35-division consumer and B2B conglomerate with annual sales of $1.2 billion.